COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1169: Articles 11681-11690  | Next

Calibrating an SIR model for South Korea COVID-19 infections and predicting vaccination impact
Pae, B.
10.1101/2021.09.27.21264172 — Posted: 2021-09-29
Secondary infections modify the overall course of hospitalized COVID-19 patients: A retrospective study from a network of hospitals across North India
Budhiraja, S., TARAI, B., JAIN, D., AGGARWAL, M., INDRAYAN, A., DAS, P., MISHRA, R. S., BALI, S., MAHAJAN, M., KIRTANI, J., TICKOO, R., SONI, P., NANGIA, V., LALL, A., KISHORE, N., JAIN, A., SINGH, O., SINGH, N., KUMAR, A., SAXENA, P., DEWAN, A., AGGARWAL, R., MEHRA, M., JAIN, M., NAKRA, V., SHARMA, B. D., PANDEY, P., SINGH, Y. P., ARORA, V., JAIN, S., CHHABRA, R., TULI, P., BOOBNA, V., JOSHI, A., AGGARWAL, M., GUPTA, R., ANEJA, P., DHALL, S., ARORA, V., CHUGH, I. M., GARG, S., MITTAL, V., GUPTA, A., JYOTI, B., SHARMA, P., BHASIN, P., JAIN, S., SINGHAL, R. K., BHASIN, A., VARDANI, A., PAL, V., PANDE, D. G., GULATI, T., NAYAR, S., KALRA, S., GARG, M., PANDE, R., BAG, P., GUPTA, A., SHARMA, J., HANDOO, A., BURMAN, P., GUPTA, A. K., CHOUDHARY, P. N., GUPTA, A., GUPTA, P., JOSHI, S., TAYAL, N., GUPTA, M., KHANNA, A., KISHORE, S., SAHAY, S., DANG, R., MISHRA, N., SEKHRI, S., SHRIVASTAVA, R. C., AGRAWAL, M. B., MATHUR, M., BANWARI, A., KHETARPAL, S., PANDOVE, S., BHASIN, D., SINGH, H., MIDHA, D., BHUTANI, A., KAUR, M., SINGH, A., SHARMA, S., SINGLA, K., GUPTA, P., SAGAR, V., DIXIT, A., BAJPAI, R., CHACHRA, V., TYAGI, P., SAXENA, S., UNIYAL, B., BELWAL, S., AIER, I., SINGHAL, M., KHANDURI, A.
10.1101/2021.09.27.21264070 — Posted: 2021-09-29
Methods for Estimation of SARS-CoV-2 Seroprevalence and Reported COVID-19 Cases in U.S. Children, August 2020 - May 2021
Couture, A., Lyons, B. C., Mehrotra, M. L., Sosa, L., Ezike, N., Ahmed, F., Brown, C. M., Yendell, S., Cope, A., Katic, B. J., Azzam, I. A., Dickerson, K., Stone, J., Traxler, L. B., Dunn, J., Davis, L. B., Reed, C., Clarke, K. E., Flannery, B., Charles, M. D.
10.1101/2021.09.26.21263756 — Posted: 2021-09-29
Mutational Signatures as Sensors of Environmental Exposures: Role of Smoking in COVID-19 Vulnerabilities
Kim, Y.-A., Hodzic, E., Saslafsky, A., Wojtowicz, D., Amgalan, B., Przytycka, T. M.
10.1101/2021.09.27.461855 — Posted: 2021-09-28
Milk casein prevents inactivation effect of black tea galloylated theaflavins on SARS-CoV-2 in vitro
Ohgitani, E., Shin-Ya, M., Ichitani, M., Kobayashi, M., Takihara, T., Saito, M., Kinugasa, H., Mazda, O.
10.1101/2021.09.27.461930 — Posted: 2021-09-28
Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
Ventero, M. P., Moreno-Perez, O., Molina-Pardines, C., Paytuvi-Gallart, A., Boix, V., Galan, I., Gonzalez-delaAleja, P., Lopez-Perez, M., Sanchez-Martinez, R., Merino, E., Rodriguez, J. C.
10.1101/2021.09.28.461924 — Posted: 2021-09-28
ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants
Seow, J., Graham, C., Hallett, S. R., Lechmere, T., Maguire, T. J. A., Huettner, I., Cox, D., Roberts, R., Waters, A., Ward, C. C., Mant, C., Pitcher, M. J., Spencer, J., Fox, J., Malim, M. H., Doores, K. J.
10.1101/2021.09.27.461862 — Posted: 2021-09-28
In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach.
Maes, M., Del Tedesco Junior, W. L., Lozovoy, M., Mori, M., Danelli, T., de Almeida, E., Tejo, A., Tano, Z., Reiche, E. M., Simao, A. N.
10.1101/2021.09.26.21264127 — Posted: 2021-09-28
Analysis of the ARTIC version 3 and version 4 SARS-CoV-2 primers and their impact on the detection of the G142D amino acid substitution in the spike protein
Davis, J., Long, S. W., Christensen, P., Olsen, R. J., Olson, R., Shukla, M., Subedi, S., Stevens, R., Musser, J. M.
10.1101/2021.09.27.461949 — Posted: 2021-09-28
The BNT162b2 mRNA vaccine induces polyfunctional T cell responses with features of longevity.
Borsellino, G., Guerrera, G., Picozza, M., D'Orso, S., Placido, R., Pirronello, M., Verdiani, A., Termine, A., Fabrizio, C., Giannessi, F., Sambucci, M., Balice, M. P., Caltagirone, C., Salvia, A., Rossini, A., Battistini, L.
10.1101/2021.09.27.462006 — Posted: 2021-09-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).